ICICI Securities research report on SBI Life Insurance Company
SBI Life Insurance (SBLI) maintains its sectoral outperformance basis volume growth (17% YoY in 9MFY24) as well as margins (28.1% in 9MFY24), resulting in higher EVoP (~20% for five years ending FY24 likely). Its distribution capacity (both in bancassurance as well as other channels) is allowing for better access in beyond-tier-1 locations, leading to volume outperformance. Basis management guidance as well as product pipeline, the company is likely to show better margin resilience around 28% levels despite EOM regulations. Maintain BUY. Key risks include regulatory changes such as smaller tax exemptions on insurance and/or higher surrender value for non-linked savings.
Outlook
We factor in VNB margins of 28% in FY25/26E and model 15% APE growth in FY25E/FY26E. This results in an EV of INR 796bn with RoEV of 18.5% in FY26E. We roll forward our estimates to FY26 and lower the multiple from 2.5x to 2.2x to accommodate any regulatory changes, including a possible increase in surrender value.
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.